Navigation Links
Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving 'Recovery Through Discovery'
Date:6/12/2009

Council for American Medical Innovation Unveils Policy Agenda at Event Co-Sponsored by The Aspen Institute

WASHINGTON, June 12 /PRNewswire-USNewswire/ -- Political leaders and health policy, research and biotechnology experts gathered at a forum today at the Newseum in Washington, D.C., to address the economic impact of policies related to U.S. medical innovation at the "Best & Brightest Forum on Medical Innovation: Achieving Recovery Through Discovery." The Council for American Medical Innovation and The Aspen Institute co-hosted the event. Senator Arlen Specter (D-PA) delivered the keynote address, in which he spoke about the enormous potential for growth in life sciences and medicine to help the economy recover and prosper.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090612/DC31512LOGO-a)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090612/DC31512LOGO-b)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/DC89081LOGO)

"It is critical to both our nation's health and economy that Congress actively supports medical research and innovation," said Senator Arlen Specter. "Federal funding and policies are vital components in encouraging scientific discoveries that have the potential to cure the world's diseases."

The Council for American Medical Innovation came together this year with a common goal of adopting and promoting a national policy a
'/>"/>

SOURCE Council for American Medical Innovation and The Aspen Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. California State Senator Shelia Kuehls Leadership in Stem Cell Debate Praised and Embryonic Stem Cell Profiteers Criticized by Repair Stem Cell Institute Spokesman
2. Batman Teams with Senator Katherine Laforge to Help Free America from OPEC
3. Richard Schulz Receives the Coveted GCPj Award for Best Clinical Researcher of the Year
4. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
5. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
6. Clinical and Economical Considerations For IV Push Drug Delivery by Industry Expert Richard Rosenfeld Is Now Accessible on Expert411.com for Media and Professional Use
7. Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
8. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
9. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
10. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
11. Cytochroma Appoints R. Richard Wieland II As CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Calif. , July 1, 2015   ... on the development of groundbreaking drugs to treat ... announced today that Robert G. Miller , ... at Sutter Health,s California Pacific Medical Center in San ... ALS Association for $1.5 million to help fund ...
(Date:7/1/2015)... ... July 01, 2015 , ... Apex Therapeutics announced today ... Convention in Philadelphia, PA. , The presentation took place on Tuesday, June ... plans for the development of APX3330 for the treatment of pancreatic cancer. A ...
(Date:6/30/2015)... 2015 /PRNewswire/ - Resverlogix Corp. ("Resverlogix") (TSX:RVX) announced ... Resverlogix have approved the resolutions relating to: (i) ... 5,600,000 units at a price of $2.67 per ... comprised of one common share and 0.075358 common ... CAD$15 million; and (ii) the amendment to Resverlogix,s ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... , Study will provide new insights on mechanics of fecal microbiota transplantation in ... partnership to study the microbiome of patients undergoing fecal microbiota transplantation (FMT) as ...
Breaking Biology Technology:Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Apex Therapeutics Presented Company Overview at This Year’s BIO International Convention in Philadelphia, PA 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3
... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced today ... present a corporate overview at the,ThinkEquity Partners, G5: The ... Eastern Time (10:30 a.m. Pacific Time) at the St. ... live audio broadcast or the subsequent archived,recording, log on ...
... CINCINNATI, Sept. 7 Kendle (Nasdaq: KNDL ... that Senior Vice President and Chief Financial Officer ... Stearns 20th Annual,Healthcare Conference at the Grand Hyatt ... City, Sept. 10-11, 2007. Kendle,s presentation is,scheduled for ...
... Sept. 7 /Xinhua-PRNewswire-FirstCall/ -- China Technology,Development Group ... today,announced the new business strategy of entering ... commitment to significantly increase China,s,use of renewable ... energy demand,CTDC strongly believes the new business ...
Cached Biology Technology:Monogram Biosciences to Present at the ThinkEquity Partners' Fifth Annual Growth Conference 2Kendle to Present at Bear Stearns 20th Annual Healthcare Conference 2China Technology Announces Entry to the Solar Energy Sector 2China Technology Announces Entry to the Solar Energy Sector 3
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:6/29/2015)... DUBLIN , June 24, 2015 ... the addition of the "Latin America Biomedical Sensors ... to their offering. The Latin America Biomedical ... at a CAGR of 2.04% over the period 2014-2020 ... that are adaptable to the genetic formulation of each ...
(Date:6/25/2015)... June 25, 2015  TAKE Solutions Ltd., a global ... the United States Patent and Trademark Office (USPTO) for ... leverages TAKE Solutions, Clinical Accelerators to reduce the time ... compared to standardization without the accelerators), thus reducing time ... At the heart of the patented Clinical ...
Breaking Biology News(10 mins):Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Latin America Biomedical Sensors Market Report 2015-2020 2TAKE Solutions Awarded Patent By USPTO 2
... Feb. 15, 2011 The risk of deadly hantavirus outbreaks ... using satellite images to monitor surges in vegetation that boost ... also might forecast outbreaks of other rodent-borne illnesses worldwide. ... to go out and trap animals all the time," says ...
... a fertilizer linchpin of modern agriculture, a team of researchers ... supply and that overuse in the industrialized world has become ... streams. Writing in the Feb. 14 edition of the ... University of Wisconsin-Madison and Elena Bennett of McGill University report ...
... unprecedented coming-out party, 100 newly discovered species are revealed to ... Museum scientists. , The 100 organisms are lichens, a type ... from arctic tundra to tropical rain forests. And the usual ... so many new ones in a single paper in the ...
Cached Biology News:Monitoring killer mice from space 2Monitoring killer mice from space 3Monitoring killer mice from space 4Monitoring killer mice from space 5World phosphorous use crosses critical threshold 2World phosphorous use crosses critical threshold 3New scholarly paper reveals 100 new species of lichenized fungi 2
... Workstation brings together UV irradiation and antimicrobial ... against PCR contamination! Quickly inactivate DNA ... a clean environment with antimicrobial coated stainless ... within minutes with built-in 30-minute timer ...
... Recombinant Enterokinase (rEK) is a highly purified ... enterokinase, a serine protease which recognizes the ... (AspAspAspAspLys?) and has similar enzymatic activity (1). ... and purified to yield the highest activity ...
... benefits of a Hybridizer and UV Crosslinker (254nm ... , This unique, new design for ... at one location , Hybridizer and Crosslinker ... other , The Crosslinker is also available ...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: